Clinical Trials Logo
  1. Home
  2. Pars Plana Vitrectomy
  3. NCT05013281

Suprachoroidal Hemorrhage Associated With Pars Plana Vitrectomy

Pars Plana Vitrectomy Clinical Trial

Official title:
Suprachoroidal Hemorrhage Associated With Pars Plana Vitrectomy

Clinical Trial Summary

To analyze the characteristics, related risk factors, and prognosis of suprachoroidal hemorrhage (SCH) associated with pars plana vitrectomy (PPV).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05013281
Study type Observational
Source Beijing Tongren Hospital
Contact
Status Completed
Phase
Start date January 1, 2010
Completion date January 28, 2021
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05990829 - Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients Diagnosed by Intraoperative OCT (the VIDEO Study): Study Protocol for a Randomized Controlled Trial Phase 4
Recruiting NCT05631054 - Establishment and Validation of a Risk Prediction Model for Long-term Low Vision After Vitrectomy in PDR Patients
Recruiting NCT05728476 - Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Diabetic Macular Edema N/A
Recruiting NCT04774146 - Quantification of Silicone Oil Emulsification After Pars Plana Vitrectomy
Completed NCT04278079 - Vitrectomy With Internal Limiting Membrane Peeling for Myopic Traction Maculopathy N/A
Not yet recruiting NCT05592912 - Safety and Efficacy of HydroLenz for Vitrectomy-Induced Lens Opacities Phase 1
Completed NCT00548197 - Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment Phase 1
Terminated NCT00936520 - SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy Phase 1
Recruiting NCT05248334 - A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabetic Retinopathy Phase 1